Holen Sie sich die Stockscreener-App
364.55
0.28%
1.1301
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$363.42
Offen:
$362.88
24-Stunden-Volumen:
655.38K
Relative Volume:
0.47
Marktkapitalisierung:
$70.65B
Einnahmen:
$321.33B
Nettoeinkommen (Verlust:
$1.57B
KGV:
45.84
EPS:
7.9518
Netto-Cashflow:
$3.21B
1W Leistung:
+1.16%
1M Leistung:
+14.96%
6M Leistung:
+30.62%
1J Leistung:
+45.79%
1-Tages-Spanne:
$361.04
$365.62
1-Wochen-Bereich:
$354.41
$366.17
52-Wochen-Spanne:
$223.92
$366.17
Cencora Inc Stock (COR) Company Profile
Firmenname
Cencora Inc
Sektor
Branche
Telefon
610-727-7000
Adresse
1 WEST FIRST AVENUE, CONSHOHOCKEN
Vergleichen Sie COR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
364.43 | 70.46B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
MCK
Mckesson Corporation
|
847.20 | 103.77B | 387.09B | 4.23B | 6.01B | 32.12 |
|
CAH
Cardinal Health Inc
|
206.29 | 48.55B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
73.17 | 8.58B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.47 | 829.29M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-09-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2023-01-31 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-10-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-12 | Fortgesetzt | Evercore ISI | In-line |
| 2021-02-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-01-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Eingeleitet | Mizuho | Neutral |
| 2020-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Eingeleitet | Barclays | Underweight |
| 2020-06-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-04-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-11 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-07-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Eingeleitet | Guggenheim | Buy |
| 2019-04-10 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-10 | Herabstufung | Jefferies | Buy → Hold |
| 2018-10-26 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Eingeleitet | Berenberg | Buy |
| 2018-07-17 | Fortgesetzt | Stifel | Hold |
| 2018-04-09 | Eingeleitet | MoffettNathanson | Buy |
| 2018-03-12 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Eingeleitet | JP Morgan | Neutral |
| 2017-09-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cencora Inc Aktie (COR) Neueste Nachrichten
How Cencora is Strengthening its US Pharma Distribution - Manufacturing Digital Magazine
How Cencora Inc. (ABG) stock reacts to weak economyEntry Point & Stepwise Trade Signal Implementation - newser.com
How Cencora Inc. (ABG) stock trades after rate cutsJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
Is Cencora Inc. (ABG) stock a buy during volatile marketsSell Signal & High Win Rate Trade Tips - newser.com
Will Cencora Inc. (ABG) stock attract long term capital inflowsBear Alert & AI Enhanced Trade Execution Alerts - newser.com
Can Cencora Inc. stock rebound after recent weaknessMarket Performance Report & Verified Stock Trade Ideas - newser.com
Why retail traders accumulate Cencora Inc. (ABG) stock2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
Is Cencora Inc. showing signs of accumulationEarnings Overview Summary & AI Powered Market Trend Analysis - newser.com
How Cencora Inc. stock compares with market leadersVolume Spike & Comprehensive Market Scan Insights - newser.com
Can Cencora Inc. (ABG) stock sustain free cash flowDollar Strength & Capital Efficiency Focused Ideas - newser.com
Ex-Dividend Reminder: Royalty Pharma, Cencora and MMM - Nasdaq
Cencora Commits $1B to U.S. Distribution Network Expansion - Modern Distribution Management
Why Cencora's (NYSE:COR) Earnings Are Better Than They Seem - Yahoo Finance
Day 7 of Gains Streak for Cencora Stock with 8.1% Return (vs. 63% YTD) [11/11/2025] - Trefis
Will Cencora Inc. stock attract more institutional investorsJuly 2025 PostEarnings & AI Based Buy/Sell Signal Reports - newser.com
COR: JP Morgan Raises Cencora's Price Target to $417 | COR Stock News - GuruFocus
Why Cencora Inc. stock could be top winnerMarket Growth Summary & Breakout Confirmation Alerts - newser.com
Wells Fargo Raises Cencora (COR) Price Target to $405 | COR Stoc - GuruFocus
What makes Cencora Inc. stock attractive to growth fundsPortfolio Return Summary & Verified Momentum Stock Ideas - newser.com
Cencora Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
Live market analysis of Cencora Inc.Weekly Volume Report & Real-Time Market Sentiment Reports - newser.com
Day 6 of Gains Streak for Cencora Stock with 7.9% Return (vs. 63% YTD) [11/10/2025] - Trefis
Will Cencora Inc. stock see insider buyingMarket Performance Report & Verified Stock Trade Ideas - newser.com
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), ALX Oncology Holdings (ALXO) and Cencora (COR) - The Globe and Mail
Cencora to invest $1B to bolster pharma network, including in Alabama - The Business Journals
How supply chain issues affect Cencora Inc. stockJuly 2025 Closing Moves & Weekly Setup with ROI Potential - newser.com
Tools to monitor Cencora Inc. recovery probability2025 Price Action Summary & Intraday High Probability Setup Alerts - newser.com
Cencora stock price target raised to $400 from $350 at TD Cowen on strong growth outlook - Investing.com South Africa
How Cencora Inc. stock reacts to job market dataFed Meeting & Risk Controlled Stock Pick Alerts - newser.com
Can Cencora Inc. stock surprise markets with earningsMarket Performance Report & Daily Risk Controlled Trade Plans - newser.com
How to read the order book for Cencora Inc.Stock Surge & Low Risk High Reward Trade Ideas - newser.com
Cencora Welcomes Lori J. Ryerkerk to Board of Directors - MSN
Finanzdaten der Cencora Inc-Aktie (COR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
2.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):